From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling

BackgroundImmune system conditions of the patient is a key factor in COVID-19 infection survival. A growing number of studies have focused on immunological determinants to develop better biomarkers for therapies.AimStudies of the insurgence of immunity is at the core of both SARS-CoV-2 vaccine devel...

Full description

Bibliographic Details
Main Authors: Filippo Castiglione, Debashrito Deb, Anurag P. Srivastava, Pietro Liò, Arcangelo Liso
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.646972/full
id doaj-f3f63c38ccfc478ab74c8c6fe18b7918
record_format Article
spelling doaj-f3f63c38ccfc478ab74c8c6fe18b79182021-09-07T05:38:52ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-09-011210.3389/fimmu.2021.646972646972From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico ModelingFilippo Castiglione0Debashrito Deb1Anurag P. Srivastava2Pietro Liò3Arcangelo Liso4Institute for Applied Computing (IAC), National Research Council of Italy (CNR), Rome, ItalyDepartment of Biochemistry, School of Applied Sciences, REVA University, Bangalore, IndiaDepartment of Life Sciences, Garden City University, Bangalore, IndiaDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United KingdomDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, ItalyBackgroundImmune system conditions of the patient is a key factor in COVID-19 infection survival. A growing number of studies have focused on immunological determinants to develop better biomarkers for therapies.AimStudies of the insurgence of immunity is at the core of both SARS-CoV-2 vaccine development and therapies. This paper attempts to describe the insurgence (and the span) of immunity in COVID-19 at the population level by developing an in-silico model. We simulate the immune response to SARS-CoV-2 and analyze the impact of infecting viral load, affinity to the ACE2 receptor, and age in an artificially infected population on the course of the disease.MethodsWe use a stochastic agent-based immune simulation platform to construct a virtual cohort of infected individuals with age-dependent varying degrees of immune competence. We use a parameter set to reproduce known inter-patient variability and general epidemiological statistics.ResultsBy assuming the viremia at day 30 of the infection to be the proxy for lethality, we reproduce in-silico several clinical observations and identify critical factors in the statistical evolution of the infection. In particular, we evidence the importance of the humoral response over the cytotoxic response and find that the antibody titers measured after day 25 from the infection are a prognostic factor for determining the clinical outcome of the infection. Our modeling framework uses COVID-19 infection to demonstrate the actionable effectiveness of modeling the immune response at individual and population levels. The model developed can explain and interpret observed patterns of infection and makes verifiable temporal predictions. Within the limitations imposed by the simulated environment, this work proposes quantitatively that the great variability observed in the patient outcomes in real life can be the mere result of subtle variability in the infecting viral load and immune competence in the population. In this work, we exemplify how computational modeling of immune response provides an important view to discuss hypothesis and design new experiments, in particular paving the way to further investigations about the duration of vaccine-elicited immunity especially in the view of the blundering effect of immunosenescence.https://www.frontiersin.org/articles/10.3389/fimmu.2021.646972/fullCOVID-19in-silico modelingvirtual cohortSARS-CoV-2immunosenescence
collection DOAJ
language English
format Article
sources DOAJ
author Filippo Castiglione
Debashrito Deb
Anurag P. Srivastava
Pietro Liò
Arcangelo Liso
spellingShingle Filippo Castiglione
Debashrito Deb
Anurag P. Srivastava
Pietro Liò
Arcangelo Liso
From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
Frontiers in Immunology
COVID-19
in-silico modeling
virtual cohort
SARS-CoV-2
immunosenescence
author_facet Filippo Castiglione
Debashrito Deb
Anurag P. Srivastava
Pietro Liò
Arcangelo Liso
author_sort Filippo Castiglione
title From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
title_short From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
title_full From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
title_fullStr From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
title_full_unstemmed From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
title_sort from infection to immunity: understanding the response to sars-cov2 through in-silico modeling
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-09-01
description BackgroundImmune system conditions of the patient is a key factor in COVID-19 infection survival. A growing number of studies have focused on immunological determinants to develop better biomarkers for therapies.AimStudies of the insurgence of immunity is at the core of both SARS-CoV-2 vaccine development and therapies. This paper attempts to describe the insurgence (and the span) of immunity in COVID-19 at the population level by developing an in-silico model. We simulate the immune response to SARS-CoV-2 and analyze the impact of infecting viral load, affinity to the ACE2 receptor, and age in an artificially infected population on the course of the disease.MethodsWe use a stochastic agent-based immune simulation platform to construct a virtual cohort of infected individuals with age-dependent varying degrees of immune competence. We use a parameter set to reproduce known inter-patient variability and general epidemiological statistics.ResultsBy assuming the viremia at day 30 of the infection to be the proxy for lethality, we reproduce in-silico several clinical observations and identify critical factors in the statistical evolution of the infection. In particular, we evidence the importance of the humoral response over the cytotoxic response and find that the antibody titers measured after day 25 from the infection are a prognostic factor for determining the clinical outcome of the infection. Our modeling framework uses COVID-19 infection to demonstrate the actionable effectiveness of modeling the immune response at individual and population levels. The model developed can explain and interpret observed patterns of infection and makes verifiable temporal predictions. Within the limitations imposed by the simulated environment, this work proposes quantitatively that the great variability observed in the patient outcomes in real life can be the mere result of subtle variability in the infecting viral load and immune competence in the population. In this work, we exemplify how computational modeling of immune response provides an important view to discuss hypothesis and design new experiments, in particular paving the way to further investigations about the duration of vaccine-elicited immunity especially in the view of the blundering effect of immunosenescence.
topic COVID-19
in-silico modeling
virtual cohort
SARS-CoV-2
immunosenescence
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.646972/full
work_keys_str_mv AT filippocastiglione frominfectiontoimmunityunderstandingtheresponsetosarscov2throughinsilicomodeling
AT debashritodeb frominfectiontoimmunityunderstandingtheresponsetosarscov2throughinsilicomodeling
AT anuragpsrivastava frominfectiontoimmunityunderstandingtheresponsetosarscov2throughinsilicomodeling
AT pietrolio frominfectiontoimmunityunderstandingtheresponsetosarscov2throughinsilicomodeling
AT arcangeloliso frominfectiontoimmunityunderstandingtheresponsetosarscov2throughinsilicomodeling
_version_ 1717764854091087872